Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration

Go back to Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
(NASDAQ: GCTK) Delayed: 1.24 -0.17 (12.06%)
Previous Close $1.41    52 Week High $ 
Open $1.34    52 Week Low $ 
Day High $1.34    P/E N/A 
Day Low $1.23    EPS $ 
Volume 142,869